Renin-angiotensin system (RAS) inhibitors are likely to reduce the development of atrial fibrillation by preventing atrial fibrosis. Strain rate (SR) imaging is a novel echocardiographic technique to quantify left atrial (LA) function. However, it has not been determined whether SR imaging is applicable for detection of LA dysfunction in hypertensive (HT) patients. We used SR imaging to assess alteration in LA function in HT patients and its modification by RAS inhibitors. SR imaging was performed in 80 HT patients and 50 age-matched normotensive (NT) subjects. HT patients were divided into two groups according to left ventricular hypertrophy (LVH) and LA dilatation. Peak SR was measured at each LA segment (septal, lateral, posterior, anterior, and inferior) and mean peak systolic SR (SR-LAs) was calculated by averaging data in each segment. Mean SR-LAs levels in the dilated LA group (1.97±0.45 s−1, n=25) and non-dilated LA group (2.15±0.57 s−1, n=55) were significantly (p<0.05) lower than that in NT subjects (2.53±0.71 s−1). Irrespective of the presence or absence of LVH, mean SR-LAs in HT patients was lower than that in NT subjects. When RAS inhibitors were used, the mean SR-LAs level in the non-dilated LA group was equivalent to that in NT subjects. In HT patients, mean SR-LAs, an index of LA reservoir function, decreases before development of LA enlargement and LVH. Treatment with RAS inhibitors appears to preserve LA reservoir function in HT patients without dilated LA. SR imaging can detect LA dysfunction in HT patients and is useful for evaluation of the therapeutic benefit on LA reservoir function.
Pearson AC, Gudipati C, Nagelhout D, Sear J, Cohen JD, Labovitz AJ : Echocardiographic evaluation of cardiac structure and function in elderly subjects with isolated systolic hypertension. J Am Coll Cardiol 1991; 17: 422–430.
Cuspidi C, Meani S, Fusi V, et al: Prevalence and correlates of left atrial enlargement in essential hypertension: role of ventricular geometry and the metabolic syndrome. The Evaluation of Target Organ Damage in Hypertension study. J Hypertens 2005; 23: 875–882.
Verdecchia P, Reboldi G, Gattobigio R, et al: Atrial fibrillation in hypertension: predictors and outcome. Hypertension 2003; 41: 218–223.
Yamaguchi H, Yoshida J, Yamamoto K, et al: Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. J Am Coll Cardiol 2004; 43: 55–60.
Goette A, Staack T, Röcken C, et al: Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000; 35: 1669–1677.
Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K : Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000; 101: 2612–2617.
Shi Y, Li D, Tardif JC, Nattel S : Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure. Cardiovasc Res 2002; 54: 456–461.
Healey JS, Baranchuk A, Crystal E, et al: Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005; 45: 1832–1839.
Inaba Y, Yuda S, Kobayashi N, et al: Strain rate imaging for noninvasive functional quantification of the left atrium: comparative studies in controls and patients with atrial fibrillation. J Am Soc Echocardiogr 2005; 18: 729–736.
Di Salvo G, Caso P, Lo Piccolo R, et al: Atrial myocardial deformation properties predict maintenance of sinus rhythm after external cardioversion of recent-onset lone atrial fibrillation: a color Doppler myocardial imaging and transthoracic and transesophageal echocardiographic study. Circulation 2005; 112: 387–395.
Modesto KM, Dispenzieri A, Cauduro SA, et al: Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. Eur Heart J 2005; 26: 173–179.
Abd El Rahman MY, Hui W, Timme J, et al: Analysis of atrial and ventricular performance by tissue Doppler imaging in patients with atrial septal defects before and after surgical and catheter closure. Echocardiography 2005; 22: 579–585.
Di Salvo G, Drago M, Pacileo G, et al: Atrial function after surgical and percutaneous closure of atrial septal defect: a strain rate imaging study. J Am Soc Echocardiogr 2005; 18: 930–933.
Yuda S, Short L, Leano R, Marwick TH : Myocardial abnormalities in hypertensive patients with normal and abnormal left ventricular filling: a study of ultrasound tissue characterization and strain. Clin Sci (Lond) 2003; 103: 283–293.
Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP : Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956–960.
Tedesco MA, Di Salvo G, Ratti G, Natale F, Iarussi D, Iacono A : Left atrial size in 164 hypertensive patients: an echocardiographic and ambulatory blood pressure study. Clin Cardiol 2001; 24: 603–607.
Stefanadis C, Dernellis J, Toutouzas P : A clinical appraisal of left atrial function. Eur Heart J 2001; 22: 22–36.
Barbier P, Alioto G, Guazzi MD : Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1994; 24: 165–170.
Nagano R, Masuyama T, Naka M, Hori M, Kamada T : Contribution of atrial reservoir function to ventricular filling in hypertensive patients. Effect of nifedipine administration. Hypertension 1995; 26: 815–819.
Okazaki H, Minamino T, Tsukamoto O, et al: Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Hypertens Res 2006; 29: 277–284.
Kahn A, Roth ZJ, Schnitzer R, Raisinghani AB, DeMaria AN : Quantitative assessment of left atrial function by 2-D strain imaging: regional variability and findings with abnormal filling dynamics. Circulation 2005; 112 ( Suppl): II-429 ( Abstract).
Varo N, Iraburu MJ, Varela M, López B, Etayo JC, Díez J : Chronic AT1 blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats. Hypertension 2000; 35: 1197–1202.
Díez J, Querejeta R, López B, González A, Larman M, Martínez Ubago JL : Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002; 105: 2512–2517.
Takeuchi K, Ideishi M, Tashiro T, et al: Higher small arterial elasticity in hypertensive patients treated with angiotensin II receptor blockers. Hypertens Res 2005; 28: 639–644.
Kumagai K, Nakashima H, Urata H, Gondo N, Arakawa K, Saku K : Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 2003; 41: 2197–2204.
Dernellis JM, Vyssoulis GP, Zacharoulis AA, Toutouzas PK : Effects of antihypertensive therapy on left atrial function. J Hum Hypertens 1996; 10: 789–794.
Mattioli AV, Bonatti S, Monopoli D, Zennaro M, Mattioli G : Influence of regression of left ventricular hypertrophy on left atrial size and function in patients with moderate hypertension. Blood Press 2005; 14: 273–278.
Engelmann MD, Svendsen JH : Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005; 26: 2083–2092.
Ciulla MM, Paliotti R, Esposito A, et al: Different effects of antihypertensive therapies based on losartan or atenolol on ultrasound and biochemical markers of myocardial fibrosis: results of a randomized trial. Circulation 2004; 110: 552–557.
Shibasaki Y, Nishine T, Masaki H, et al: Impact of the angiotensin II receptor antagonists, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers. Hypertens Res 2005; 28: 787–795.
About this article
Cite this article
Kokubu, N., Yuda, S., Tsuchihashi, K. et al. Noninvasive Assessment of Left Atrial Function by Strain Rate Imaging in Patients with Hypertension: A Possible Beneficial Effect of Renin-Angiotensin System Inhibition on Left Atrial Function. Hypertens Res 30, 13–21 (2007). https://doi.org/10.1291/hypres.30.13
- strain rate imaging
- left atrium
- renin-angiotensin system inhibitors
Early detection of left atrial dysfunction assessed by CMR feature tracking in hypertensive patients
European Radiology (2020)
European Heart Journal (2020)
The anti-Alzheimer effect of telmisartan in a hyperglycemic ovariectomized rat model; role of central angiotensin and estrogen receptors
Food and Chemical Toxicology (2020)
Association of Asymptomatic Diastolic Dysfunction Assessed by Left Atrial Strain With Incident Heart Failure
JACC: Cardiovascular Imaging (2020)